Clinical trial
Specific Effects of Escitalopram on Neuroendocrine Response
NCT00150527 · Queen's University, Other · Completed
Key facts
| NCT number | NCT00150527 |
|---|---|
| Title | Specific Effects of Escitalopram on Neuroendocrine Response |
| Official title | Specific Effects of Escitalopram on Neuroendocrine Response |
| Lead sponsor | Queen's University, Other |
| Collaborators | H. Lundbeck A/S Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Healthy |
| Intervention type | Behavioral, Drug |
| Interventions | Citalopram, Escitalopram, Dexamethasone, Cold Pressor Test |
| Enrollment | 8 |
| Start date | Sep 1, 2005 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2007 |
| First posted | Sep 8, 2005 |
| Last update posted | Feb 5, 2009 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: